RHUMBLINE ADVISERS - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 67 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2018$33,000
-36.5%
23,0930.0%0.00%
Q4 2017$52,000
-34.2%
23,0930.0%0.00%
Q3 2017$79,0000.0%23,093
+3.6%
0.00%
Q2 2017$79,000
+54.9%
22,298
+49.6%
0.00%
Q1 2017$51,000
-21.5%
14,908
+6.1%
0.00%
Q4 2016$65,000
+25.0%
14,050
+14.6%
0.00%
Q3 2016$52,000
+85.7%
12,264
+5.1%
0.00%
Q2 2016$28,000
-34.9%
11,664
+4.2%
0.00%
Q3 2015$43,00011,1990.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 5,292,156$7,144,0000.82%
Northeast Financial Consultants Inc 732,265$988,0000.30%
Family Management Corp 10,424$14,0000.01%
LMR Partners LLP 81,550$110,0000.01%
ELEMENT CAPITAL MANAGEMENT LLC 148,528$201,0000.01%
Poehling Capital Management, INC. 3,302$4,0000.00%
Paloma Partners Management Co 143,800$194,0000.00%
Founders Capital Management 3,000$4,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 186,254$251,0000.00%
FNY Investment Advisers, LLC 4,230$5,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders